milrinone has been researched along with vesnarinone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Alvarez, R; Bruno, JJ; Jones, GH; Venuti, MC | 1 |
| Baughman, KL; Feldman, AM; Strobeck, JE | 1 |
| Blinks, JR; Endoh, M; Taira, N; Yanagisawa, T | 1 |
| Han, W; Qin, Y; Yang, Z; Zhang, Z; Zhou, S | 1 |
| Lan, T; Li, H; Zeng, X; Zhang, Y | 1 |
| Pritzker, MR | 1 |
| Battagliese, A; Bucciarelli Ducci, C; Celotto, A; De Luca, L; Fedele, F; Palombaro, GL; Proietti, P | 1 |
2 review(s) available for milrinone and vesnarinone
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
New positive inotropic agents in the treatment of left ventricular dysfunction.
Topics: Cardiotonic Agents; Diastole; Heart Failure; Humans; Hydrazones; Milrinone; Myocardial Ischemia; Phosphodiesterase Inhibitors; Pyrazines; Pyridazines; Quinolines; Simendan; Ventricular Dysfunction, Left; Ventricular Function, Left | 2004 |
1 trial(s) available for milrinone and vesnarinone
| Article | Year |
|---|---|
Oral milrinone in severe chronic heart failure.
Topics: Cardiotonic Agents; Heart Failure; Humans; Milrinone; Pyrazines; Pyridones; Quinolines | 1992 |
6 other study(ies) available for milrinone and vesnarinone
| Article | Year |
|---|---|
Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Dogs; Humans; Imidazoles; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Myocardium; Quinazolines; Quinolines; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1987 |
Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Enoximone; Female; Imidazoles; Male; Milrinone; Myocardial Contraction; Myocardium; Nifedipine; Nucleotides, Cyclic; Pyrazines; Pyridones; Quinolines; Time Factors | 1986 |
[Inotropic effect of novel domestic cardiotonic agent, vesnarinone--test in vitro].
Topics: Amrinone; Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Guinea Pigs; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Pyrazines; Pyridones; Quinolines; Rabbits; Stimulation, Chemical | 1994 |
[Effects of vesnarinone on L-type single Ca2+ channel current in cultured ventricular myocytes of embryonic chick].
Topics: Animals; Calcium Channels; Cardiotonic Agents; Cells, Cultured; Chick Embryo; Milrinone; Myocardium; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrazines; Pyridones; Quinolines | 1995 |
Severe heart failure: balancing length and quality of life.
Topics: Amrinone; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyrazines; Quality of Life; Quinolines | 1999 |
Chronic heart failure and the quality of life.
Topics: Cardiotonic Agents; Heart Failure; Humans; Milrinone; Palliative Care; Pyrazines; Quality of Life; Quinolines | 1999 |